Anti-FGF13 antibody produced in mouse
SIGMA/SAB1405809 - purified immunoglobulin, buffered aqueous solution
Synonym: FGF2; FHF2
Product Type: Chemical
Western Blotting Western Blot analysis of FGF13 expression in transfected 293T cell line by FGF13 polyclonal antibody. Lanes Lane 1: FGF13 transfected lysate (26.95 kDa). Lane 2: Non-transfected lysate.
| antibody form | purified immunoglobulin |
| antibody product type | primary antibodies |
| biological source | mouse |
| clone | polyclonal |
| conjugate | unconjugated |
| form | buffered aqueous solution |
| mol wt | antigen ~27.6 kDa |
| NCBI accession no. | NM_004114   |
| Quality Level | 100 |
| shipped in | dry ice |
| species reactivity | human |
| storage temp. | −20°C |
| target post-translational modification | unmodified |
| technique(s) | western blot: 1 μg/mL |
| UniProt accession no. | Q92913 |
| General description: | The protein encoded by this gene is a member of the fibroblast growth factor (FGF) family. FGF family members possess broad mitogenic and cell survival activities, and are involved in a variety of biological processes, including embryonic development, cell growth, morphogenesis, tissue repair, tumor growth, and invasion. This gene is located in a region on chromosome X, which is associated with Borjeson-Forssman-Lehmann syndrome (BFLS), making it a possible candidate gene for familial cases of the BFLS, and for other syndromal and nonspecific forms of X-linked mental retardation mapping to this region. Alternative splicing of this gene at the 5′ end results in several transcript variants encoding different isoforms with different N-termini. (provided by RefSeq) |
| Immunogen: | FGF13 (NP_004105.1, 1 a.a. ~ 245 a.a) full-length human protein. Sequence MAAAIASSLIRQKRQAREREKSNAC |
| Physical form: | Solution in phosphate buffered saline, pH 7.4 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 1 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Storage Temp. | −20°C |
| UNSPSC | 12352203 |